AstraZeneca wins fight to protect patent
Published Date:
03 July 2008
Drugs giant AstraZeneca yesterday celebrated its latest victory in the battle to protect its most valuable medicines from cheaper, unauthorised copies.
The company sued two firms for trying to market generic versions of Seroquel, a treatment for schizophrenia and bipolar depression. The drug was the Macclesfield-based firm's second best selling drug last year, generating revenues of $4bn (£2bn).
Astra brought the case against Israel-based Teva Pharmaceutical Industries and US drugs firm Sandoz, which both specialise in making generic medicines. They were both seeking to produce versions of Seroquel before a patent ran out in 2011, Astra said.
A US District Court in New Jersey granted the company's motion complaining that its patent had been infringed.
The full article contains 123 words and appears in n/a newspaper.
-
Last Updated:
03 July 2008 8:03 AM
-
Source:
n/a
-
Location:
Yorkshire
